The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.91%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.89%. September E-mini...
Insulet has outperformed the Medical Devices industry over the past year, and analysts are highly optimistic about the stock’s prospects.
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TNDM),(NYSE:NVO),(NASDAQ:PODD),(NYSE:MDT) EQNX::TICKER_END
DexCom has underperformed the Health Care sector over the past year, but analysts are highly optimistic about the stock’s prospects.
Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns.
Insulet has significantly outpaced the broader market over the past year, and analysts remain bullish on the stock’s prospects.
Insulet's earnings and upgraded guidance recently propelled its stock to S&P 500 leadership, showcasing strong execution in the diabetes care market.
U.S. stocks rallied after China and the United States announced a 90-day truce in their trade war